Douglas C. Lane & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $28M | Sell |
407,029
-7,552
| -2% | -$520K | 0.76% | 53 |
|
|
2015
Q3 | $24.5M | Sell |
414,581
-22,249
| -5% | -$1.32M | 0.7% | 55 |
|
|
2015
Q2 | $29.1M | Sell |
436,830
-17,891
| -4% | -$1.19M | 0.78% | 54 |
|
|
2015
Q1 | $29.3M | Sell |
454,721
-10,912
| -2% | -$704K | 0.77% | 54 |
|
|
2014
Q4 | $27.5M | Sell |
465,633
-3,837
| -0.8% | -$226K | 0.74% | 54 |
|
|
2014
Q3 | $24M | Buy |
469,470
+1,136
| +0.2% | +$58.1K | 0.72% | 57 |
|
|
2014
Q2 | $22.7M | Sell |
468,334
-8,170
| -2% | -$396K | 0.69% | 60 |
|
|
2014
Q1 | $24.8M | Sell |
476,504
-16,702
| -3% | -$868K | 0.79% | 56 |
|
|
2013
Q4 | $26.2M | Sell |
493,206
-100,881
| -17% | -$5.36M | 0.87% | 49 |
|
|
2013
Q3 | $27.5M | Sell |
594,087
-88,547
| -13% | -$4.1M | 1% | 40 |
|
|
2013
Q2 | $30.5M | Buy |
+682,634
| New | +$30.5M | 1.19% | 32 |
|